Divisadero Street Capital Management LP Acquires 296,481 Shares of Viemed Healthcare, Inc. (NASDAQ:VMD)

Divisadero Street Capital Management LP raised its position in Viemed Healthcare, Inc. (NASDAQ:VMD - Free Report) by 84.8% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 646,273 shares of the company's stock after buying an additional 296,481 shares during the quarter. Divisadero Street Capital Management LP owned about 1.66% of Viemed Healthcare worth $5,183,000 at the end of the most recent reporting period.

Other institutional investors have also recently made changes to their positions in the company. R Squared Ltd purchased a new position in Viemed Healthcare in the 4th quarter valued at approximately $41,000. Corton Capital Inc. bought a new position in shares of Viemed Healthcare in the fourth quarter worth $82,000. EntryPoint Capital LLC purchased a new position in shares of Viemed Healthcare in the fourth quarter valued at $92,000. Prudential Financial Inc. bought a new stake in shares of Viemed Healthcare during the 4th quarter valued at $93,000. Finally, Oxford Asset Management LLP bought a new stake in shares of Viemed Healthcare during the 4th quarter valued at $98,000. Hedge funds and other institutional investors own 74.24% of the company's stock.

Viemed Healthcare Price Performance

NASDAQ VMD traded up $0.14 during trading hours on Monday, hitting $6.46. The company had a trading volume of 136,738 shares, compared to its average volume of 140,958. The company has a debt-to-equity ratio of 0.03, a quick ratio of 1.19 and a current ratio of 1.31. The firm has a market capitalization of $255.13 million, a price-to-earnings ratio of 23.91 and a beta of 1.49. Viemed Healthcare, Inc. has a 52 week low of $5.85 and a 52 week high of $9.81. The firm has a 50 day simple moving average of $7.07 and a 200 day simple moving average of $7.91.

Viemed Healthcare (NASDAQ:VMD - Get Free Report) last announced its quarterly earnings results on Wednesday, May 7th. The company reported $0.06 earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of $0.06. Viemed Healthcare had a net margin of 4.87% and a return on equity of 8.72%. The firm had revenue of $59.10 million for the quarter, compared to the consensus estimate of $60.60 million.

Viemed Healthcare Profile

Viemed Healthcare, Inc, together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.